Document:

EX-10.30

 Exhibit 10.30 

THIS WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE
STATE SECURITIES LAWS. NO SALE, DISPOSITION, PLEDGE, HYPOTHECATION, OR OTHER TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT
REQUIRED. 
 GREAT BASIN SCIENTIFIC, INC. 

WARRANT TO PURCHASE [COMMON STOCK] [PREFERRED STOCK] 

[                    ] 

THIS WARRANT is issued to [            ] (the “Holder”), by Great
Basin Scientific, Inc., a Delaware corporation (the “Company”). 
 1. Purchase of Shares. Subject to the terms and
conditions hereinafter set forth, the Holder is entitled, upon surrender of this Warrant at the principal office of the Company (or at such other place as the Company shall notify the holder hereof in writing), during the period specified in
Section 2 hereof, to purchase from the Company up to [                ] shares of fully-paid and non-assessable common stock of the Company (the
“Shares”) at a price per share of $[            ], subject to adjustment as provided in Section 6 below (the “Exercise Price”). 

2. Duration. This Warrant and the right to subscribe for and purchase Shares hereunder shall be immediately exercisable upon the date
hereof and shall expire automatically, if not previously exercised, upon the earlier of (a) five years from the date hereof; (b) a Change of Control (as defined below); or (c) a liquidation, dissolution or winding up of the Company.
For purposes hereof, “Change of Control” means (A) the acquisition of the Company by another entity by means of any transaction or series of related transactions (including, without limitation, any reorganization, merger or
consolidation or stock transfer, but excluding any such transaction effected primarily for the purpose of changing the domicile of the Company), unless the Company’s stockholders of record immediately prior to such transaction or transactions
hold, immediately after such transaction or transactions, at least 50% of the voting power of the surviving or acquiring entity (excluding any sale of securities solely for the purposes of raising additional funds); or (B) a sale of all or
substantially all of the assets of the Company. 
 3. Exercise of Warrant. While this Warrant remains outstanding and exercisable in
accordance with Section 2 above, the Holder may exercise, in whole or in part, the purchase rights evidenced hereby by: 
 (i)
surrendering the Warrant, together with a duly executed notice of exercise attached hereto as Exhibit A, to the principal executive office of the Company; and 

 (ii) delivering payment to the Company of an amount equal to the aggregate Exercise Price for
the number of Shares being purchased (by cash, cashier’s check or wire transfer in an amount equal to the applicable Exercise Price); 

4. Issuance of Shares. The Shares purchased hereunder shall be issued in the name of the Holder and certificates, if issued, shall be
delivered to the Holder within a reasonable time after the date this Warrant is exercised in accordance with the terms hereof. The shares issued upon exercise of this Warrant shall be deemed to have been issued as of the close of business on the
date on which this Warrant shall have been exercised regardless of the date of delivery of such certificate, except that, if the date of exercise is a date when the stock transfer books of the Company are closed, the Holder shall be deemed to have
become the holder of such Shares at the close of business on the next succeeding date on which the stock transfer books are open. 
 5.
No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant, but in lieu of such fractional shares, the Company shall make a cash payment therefor on the basis
of the Exercise Price then in effect. 
 6. Adjustment of Exercise Price and Number of Shares. The Exercise Price and the number of
shares purchasable hereunder are subject to adjustment from time to time as follows: 
 (a) Subdivisions, Combinations and Other
Issuances. If the Company shall at any time prior to the expiration of this Warrant subdivide the shares of its common stock, by split or otherwise, or combine the shares of its common stock, or issue additional shares of its common stock as a
dividend, the number of Shares issuable on the exercise of this Warrant shall forthwith be proportionately increased in the case of a subdivision or stock dividend, or proportionately decreased in the case of a combination. Appropriate adjustments
shall also be made to the Exercise Price payable per share, but the aggregate purchase price payable for exercise of the total number of Shares purchasable under this Warrant (as adjusted) shall remain the same. Any adjustment under this
Section 6(a) shall become effective at the close of business on the date the subdivision or combination becomes effective, or as of the record date of such dividend, or in the event that no record date is fixed, upon the making of such
dividend. 
 (b) Reclassification, Reorganization and Consolidation. In case of any reclassification, capital reorganization, or
change in the capital stock of the Company (other than as a result of a subdivision, combination, or stock dividend provided for in Section 6(a) above), then the Company shall make appropriate provision so that the Holder shall have the
right at any time prior to the expiration of this Warrant to purchase the kind and amount of shares of stock and other securities and property as were receivable in connection with such reclassification, reorganization, or change by a holder of the
same number of Shares as were exercisable by the Holder immediately prior to such reclassification, reorganization, or change. In any such case, appropriate provisions shall be made with respect to the rights and interest of the Holder so that the
provisions hereof shall thereafter be applicable with respect to such shares of stock or other securities and property deliverable upon exercise hereof, and appropriate adjustments shall be made to the Exercise Price payable hereunder so that the
aggregate purchase price payable for exercise of such shares or other securities and property shall equal the aggregate purchase price payable for exercise of the total number of Shares as were exercisable hereunder immediately prior to such
reclassification, reorganization or change. 

  
 2 

 (c) Notice of Adjustment. When any adjustment is required to be made in the number of
Shares or securities or other property purchasable upon exercise of the Warrant, or in the Exercise Price, the Company shall promptly notify the holder of such event and of the number of Shares or other securities or property thereafter purchasable
upon exercise of this Warrant. 
 7. Representations of the Company. The Company represents that all corporate actions on the part of
the Company, its officers, directors and stockholders necessary for the sale and issuance of this Warrant have been taken prior to the issuance hereof. 

8. Representations and Warranties of the Holder. By acceptance of this Warrant, the Holder represents and warrants to the Company as
follows: 
 (a) This Warrant and the Shares issuable upon exercise thereof are being acquired for the Holder’s own account, for
investment and not with a view to, or for resale in connection with, any distribution or public offering thereof within the meaning of the Securities Act of 1933, as amended (the “Act”). 

(b) The Holder understands that the Warrant and the Shares have not been registered under the Act by reason of their issuance in a transaction
exempt from the registration and prospectus delivery requirements of the Act pursuant to section 4(2) thereof or Regulation S, and that they must be held by the Holder indefinitely, and that the Holder must therefore bear the economic risk of
such investment indefinitely, unless a subsequent disposition thereof is registered under the Act or is exempted from such registration. 

(c) The Holder understands that no public market now exists for any of the securities issued by the Company and that there can be no assurance
that a public market will ever exist for any of the Company’s securities. 
 (d) The Holder is aware of the Company’s business
affairs and financial condition, and has acquired information about the Company sufficient to reach an informed and knowledgeable decision to purchase the Warrant and the Shares. The Holder has such knowledge and experience in financial and business
matters that the Holder is capable of evaluating the merits and risks of the purchase of this Warrant and the Shares purchasable pursuant to the terms of this Warrant and of protecting the Holder’s interests in connection therewith. The Holder
is able to bear the economic risk of the purchase of this Warrant and the Shares. 
 (e) The Holder is an “accredited investor” as
such term is defined in Rule 501 of Regulation D promulgated under the Act. 
 9. No Rights as Stockholders. This Warrant does not
entitle the Holder to any voting rights or other rights as a stockholder of the Company prior to the exercise hereof. 

  
 3 

 10. Loss, Theft, Destruction or Mutilation of Warrant. Upon receipt by the Company of
evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it, and upon reimbursement to the Company of all
reasonable expenses incidental thereto, and upon surrender and cancellation of this Warrant, if mutilated, the Company will make and deliver a new Warrant of like tenor, in lieu of this Warrant. 

11. Restrictions on Transfer; Lock-Up. 

(a) Restrictions on Transfer of Warrant. This Warrant is not transferable, whether by sale, pledge or other disposition, voluntarily or
by operation of law or otherwise without the prior written consent of the Company, which consent may be withheld in the Company’s sole discretion. Any transfer in violation hereof shall be void and the Warrant shall terminate immediately upon
any such purported transfer. 
 (b) Restrictions on Transfers of Shares. Prior to transferring any Shares, the Holder shall deliver
to the Company a written notice stating: (i) the Holder’s bona fide intention to make a permitted transfer of its Shares; (ii) the name, address and phone number of each proposed transferee; (iii) the aggregate number of Shares
to be transferred to each proposed transferee; and (iv) the exemptions under applicable state and federal securities laws upon which Purchaser is relying in making the proposed transfer. The Holder shall also deliver to the Company a written
agreement executed by the transferee or other recipient of Shares pursuant to which such transferee agrees to be bound by the transfer restrictions set forth herein as was the Holder and an opinion of legal counsel reasonably acceptable to the
Company in a form reasonably acceptable to the Company that the transfer is exempt from registration. The Holder agrees that to ensure compliance with the restrictions referred to herein, the Company may issue appropriate “stop transfer”
instructions to its transfer agent, if any, and that, if the Company transfers its own securities, it may make appropriate notations to the same effect in its own records. The Company shall not be required (a) to transfer on its books any
Shares that have been sold or otherwise transferred in violation of any of the provisions of this agreement or (b) to treat as owner of such Shares or to accord the right to vote or pay dividends to any purchaser or other transferee to whom
such Shares shall have been so transferred. 
 (c) Holder shall not sell or otherwise transfer, make any short sale of, grant any option for
the purchase of, or enter into any hedging or similar transaction with the same economic effect as a sale, of any common stock (or other securities) of the Company held by such Holder (other than those included in the registration) during the
180-day period following the effective date of a registration statement of the Company filed under the Act (or such other period as may be requested by an underwriter to accommodate regulatory restrictions contained in applicable NASD rules or
exchange rules). The Company may impose stop-transfer instructions until the end of such 180-day (or other) period. Holder shall execute a market standoff agreement with said underwriters in customary form consistent with the provisions of this
Section 11. 

  
 4 

 12. Restrictive Legends. The Holder understands and agrees that the Company shall cause
the legends set forth below, or substantially equivalent legends, to be placed upon any certificate(s) evidencing ownership of the Shares, together with any other legends that may be required by the Company or by applicable state or federal
securities laws: 
 THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE
SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT OF 1933, AS AMENDED, AND VARIOUS APPLICABLE STATE SECURITIES LAWS. THESE SECURITIES MAY NOT BE SOLD, TRANSFERRED, PLEDGED OR
ASSIGNED OR A SECURITY INTEREST CREATED THEREIN, UNLESS THE PURCHASER, TRANSFEREE, ASSIGNEE, PLEDGEE OR HOLDER OF SUCH SECURITY INTEREST COMPLIES WITH ALL STATE AND FEDERAL SECURITIES LAWS (I.E., SUCH SECURITIES ARE REGISTERED UNDER SUCH LAWS OR AN
EXEMPTION FROM REGISTRATION IS AVAILABLE THEREUNDER) AND UNLESS THE SELLER, TRANSFEROR, ASSIGNOR, PLEDGOR OR GRANTOR OF SUCH SECURITY INTEREST PROVIDES AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY THAT THE TRANSACTION CONTEMPLATED
WOULD NOT BE IN VIOLATION OF THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE SECURITIES LAWS. 
 THE SECURITIES EVIDENCED BY
THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD WITHIN THE UNITED STATES OR TO, OR FOR THE ACCOUNT OR BENEFIT OF, U.S. PERSONS, EXCEPT AS
SET FORTH BELOW. BY ITS ACQUISITION HEREOF, THE HOLDER: (1) REPRESENTS THAT IT IS NOT A U.S. PERSON AND IS ACQUIRING THESE SHARES IN AN OFFSHORE TRANSACTION; (2) AGREES THAT IT WILL NOT RESELL OR OTHERWISE TRANSFER THESE SHARES EXCEPT
(A) TO THE COMPANY OR ANY SUBSIDIARY THEREOF, (B) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT, (C) INSIDE THE UNITED STATES, TO A QUALIFIED INSTITUTIONAL BUYER IN COMPLIANCE WITH RULE 144A UNDER THE ACT,
(D) INSIDE THE UNITED STATES, TO AN ACCREDITED INVESTOR THAT, PRIOR TO SUCH TRANSFER, FURNISHES TO THE COMPANY A SIGNED LETTER CONTAINING CERTAIN REPRESENTATIONS AND AGREEMENTS RELATING TO THE RESTRICTIONS ON TRANSFER OF THESE SHARES (THE FORM
OF WHICH LETTER CAN BE OBTAINED FROM THE COMPANY), (E) OUTSIDE THE UNITED STATES, IN AN OFFSHORE TRANSACTION IN COMPLIANCE WITH RULES 904 AND 905 UNDER THE ACT, OR (F) PURSUANT TO THE EXEMPTION FROM REGISTRATION PROVIDED BY RULE 144 UNDER
THE ACT (IF AVAILABLE); AND (3) AGREES THAT IT WILL GIVE EACH PERSON TO WHOM THESE SHARES ARE TRANSFERRED A NOTICE SUBSTANTIALLY TO THE EFFECT OF THIS LEGEND. IN CONNECTION 

  
 5 

 
WITH ANY TRANSFER OF THESE SHARES PURSUANT TO CLAUSES (C), (D) OR (F) ABOVE, THE HOLDER MUST, PRIOR TO SUCH TRANSFER, FURNISH TO THE COMPANY SUCH CERTIFICATIONS, LEGAL OPINIONS OR OTHER
INFORMATION AS THE COMPANY MAY REASONABLY REQUIRE TO CONFIRM THAT SUCH TRANSFER IS BEING MADE PURSUANT TO AN EXEMPTION OR IN A TRANSACTION NOT SUBJECT TO THE REGISTRATION REQUIREMENTS OF THE ACT. AS USED HEREIN, THE TERMS ‘OFFSHORE
TRANSACTION,’ ‘UNITED STATES,’ AND ‘U.S. PERSON’ HAVE THE MEANING GIVEN TO THEM BY REGULATION S UNDER THE ACT.” 

13. Notices. All notices required or permitted hereunder shall be in writing, shall be effective when given, and shall in be deemed
given upon receipt or, if earlier, (a) five days after deposit with the U.S. Postal Service or other applicable postal service, if delivered by first class mail, postage prepaid, (b) upon delivery, if delivered by hand, (c) one
business day after the business day of deposit with internationally recognized overnight courier, freight prepaid or (d) one business day after the business day of facsimile transmission, if delivered by facsimile transmission with copy by
first class mail, postage prepaid, and shall be addressed: 
 (a) if to the Holder at such Holder’s address as shown on the books of
the Company or its transfer agent, or at such other address as the Holder may designate by notice to the Company, and 
 (b) if to the
Company at the address of its principal corporate offices (attention: President), or at such other address as the Company may designate by notice to the Holder. 

14. Governing Law. This Warrant and all rights, obligations and liabilities hereunder shall be governed by and construed under the
corporate laws of the State of Delaware, and as to all matters other than those to which corporate law applies, this Warrant shall be governed by the laws of the State of Delaware as they apply to contracts entered into wholly to be performed within
the State of Delaware by residents thereof. 
 15. Rights and Obligations Survive Exercise of Warrant. Unless otherwise provided
herein, the rights and obligations of the Company, of the Holder and of the holder of the Shares issued upon exercise of this Warrant, shall survive the exercise of this Warrant. 

[Remainder of page intentionally left blank.] 

  
 6 

 IN WITNESS WHEREOF, the Company has caused this Warrant to be issued as of the date first set
forth above. 
  

			
	 COMPANY:

		
		 	GREAT BASIN SCIENTIFIC, INC.
		
		 	  

		 	Ryan Ashton
		 	PresidentEX-10.31

 Exhibit 10.31 

THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER ANY STATE
SECURITIES LAWS. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED, SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF A REGISTRATION STATEMENT IN EFFECT WITH RESPECT TO THESE
SECURITIES UNDER THE ACT OR APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY THAT ANY PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE WITH THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS. 

WARRANT TO PURCHASE 

SHARES OF COMMON STOCK 

OF 
 GREAT BASIN
SCIENTIFIC, INC. 
 VOID AFTER EXPIRATION DATE (DEFINED HEREIN) 

This warrant (the “Warrant”) is issued, for good and valuable consideration, receipt of which is hereby
acknowledged, to [                    ] (“Holder”), by Great Basin Scientific, Inc., a Delaware corporation (the
“Company”), effective as of [                    ], (the “Warrant Issue Date”). 

1. Purchase of Shares. 

(a) Number of Shares. Subject to the terms, conditions and adjustments hereinafter set forth, the Holder is entitled,
upon surrender of this Warrant at the principal office of the Company at the address specified in Section 15 herein (or at such other place as the Company shall notify the Holder hereof in writing), to purchase from the Company up to
[                    ] fully paid and nonassessable shares of the Company’s Common Stock, no par value per share (the “Common
Stock”). 
 (b) Exercise Price. The exercise price for the shares of Common Stock shall be
$[        ] per share (such price, as adjusted from time to time, is referred to as the “Exercise Price”). 

2. Exercise Period. This Warrant shall be exercisable, in whole or in part, during the term beginning on the Warrant Issue Date and
ending at 5:00 p.m., Salt Lake City, Utah time, on [                    ] (the “Expiration
Date”); provided, however, this Warrant shall no longer be exercisable and become null and void upon the consummation of any “Termination
Event” defined as (a) the consummation of the sale or disposition by the Company of all or substantially all of the Company’s assets or its business; (b) the consummation of a merger, reverse merger or
consolidation of the Company with any other corporation, other than a merger, or consolidation which would result in the voting securities of the company outstanding immediately prior thereto continuing to represent (either by remaining outstanding
or by being converted into voting 

 securities of the surviving entity) at least 50% of the total voting power represented by the
voting securities of the Company of such surviving entity outstanding immediately after such merger or consolidation; or (c) the consummation of the transfer (whether by merger, consolidation or otherwise), in one transaction or series of
related transactions, to a person or group of affiliated persons, of this Company’s securities, if after such consummation, such person or group of affiliated persons would hold 50% or more of the outstanding voting stock of the Company (or the
surviving or acquiring entity). In the event of a Termination Event, the Company shall notify the Holder at least five (5) days prior to the consummation of such Termination Event. 

3. Method of Exercise. While this Warrant remains outstanding and is exercisable in accordance with Section 2 above, the Holder
may exercise, in whole or in part, the purchase rights evidenced hereby. Such exercise shall be effected by: 
 (a) the
surrender of the Warrant, together with a duly executed copy of the form of Notice of Exercise attached hereto, to the Secretary of the Company at its principal offices at the address specified in Section 15 herein; and 

(b) the payment to the Company of a cash amount equal to the aggregate Exercise Price for the number of shares of Common Stock
being purchased. 
 4. Certificates for Shares. Upon the exercise of the purchase rights evidenced by this Warrant, one or more
certificates for the number of shares of Common Stock so purchased shall be issued as soon as practicable thereafter (with appropriate restrictive legends, if applicable), and in any event within 30 days of the delivery of the subscription
notice. 
 5. Issuance of Shares. The Company covenants that the Common Stock, when issued pursuant to the exercise of this Warrant,
will be duly and validly issued, fully paid and nonassessable and free from all taxes, liens and charges with respect to the issuance thereof. 

6. Adjustment of Exercise Price and Number of Shares. The number and kind of securities purchasable upon exercise of this Warrant and
the Exercise Price shall be subject to adjustment from time to time as follows: 
 (a) Subdivisions, Combinations and
Other Issuances. If the Company shall at any time prior to the expiration of this Warrant subdivide its Common Stock, by split-up or otherwise, or combine its Common Stock, or issue additional shares of its Common Stock as a dividend with
respect to any shares of its Common Stock, the number of shares of Common Stock issuable upon the exercise of this Warrant shall forthwith be proportionately increased in the case of a subdivision or stock dividend, or proportionately decreased in
the case of a combination. Appropriate adjustments shall also be made to the purchase price payable per share, but the aggregate purchase price payable for the total number of shares of Common Stock purchasable under this Warrant (as adjusted) shall
remain the same. Any adjustment under this Section 6(a) shall become effective at the close of business on the date the subdivision or combination becomes effective, or as of the record date of such dividend, or in the event that no record date
is fixed, upon the making of such dividend. 

  
 2 

 (b) Reclassification, Reorganization or Change. In case of any
reclassification, capital reorganization or change in the Common Stock of the Company (other than as a result of a subdivision, combination or stock dividend provided for in Section 6(a) above), then, as a condition of such reclassification,
reorganization or change, lawful provision shall be made, and duly executed documents evidencing the same from the Company or its successor shall be delivered to the Holder, so that the Holder shall have the right at any time prior to the expiration
of this Warrant to purchase, at a total price equal to that payable upon the exercise of this Warrant, the kind and amount of shares of stock and other securities and property receivable in connection with such reclassification, reorganization or
change by a holder of the same number of shares of Common Stock as were purchasable by the Holder immediately prior to such reclassification, reorganization or change. In any such case appropriate provisions shall be made with respect to the rights
and interest of the Holder so that the provisions hereof shall thereafter be applicable with respect to any shares of stock or other securities and property deliverable upon exercise hereof, and appropriate adjustments shall be made to the purchase
price per share payable hereunder, provided the aggregate purchase price shall remain the same. 
 (c) Notice of
Adjustment. When any adjustment is required to be made in the number or kind of shares purchasable upon exercise of the Warrant, or in the Exercise Price, the Company shall promptly notify the Holder of such event and of the number of shares of
Common Stock or other securities or property thereafter purchasable upon exercise of this Warrant. 
 7. No Fractional Shares or Scrip.
No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant, but in lieu of such fractional shares the Company shall make a cash payment therefore on the basis of the Exercise Price then in
effect. 
 8. No Shareholder Rights. Prior to the exercise of this Warrant, the Holder shall not be entitled to any rights of a
shareholder with respect to the Common Stock, including (without limitation) the right to vote such Common Stock, receive dividends or other distributions thereon, exercise preemptive rights or be notified of shareholder meetings, and such holder
shall not be entitled to any notice or other communication concerning the business or affairs of the Company. However, nothing in this Section 8 shall limit the right of the Holder to be provided any notices required under this Warrant.
Furthermore, nothing in this Section 8 nor in this Warrant shall be construed to limit, abrogate, or otherwise affect the Holder’s rights, if any, with respect to other securities, interests, equity, ownership, or stock in the Company.

 9. Transfers of Warrant. This Warrant may be transferred only upon the written consent of the Company. 

10. Successors and Assigns. Subject to Section 9, the terms and provisions of this Warrant shall inure to the
benefit of, and be binding upon, the Company and the Holder hereof and their respective successors and assigns. 

  
 3 

 11. Amendments and Waivers. ANY PROVISION OF THIS NOTE MAY BE AMENDED, WAIVED, MODIFIED,
DISCHARGED OR TERMINATED SOLELY UPON THE WRITTEN CONSENT OF BOTH THE COMPANY AND THE HOLDER. 
 12. Attorneys’ Fees. If any
action of law or equity is necessary to enforce or interpret the terms of this Warrant, the prevailing party shall be entitled to its reasonable attorneys’ fees, costs and disbursements in addition to any other relief to which it may be
entitled. 
 13. Captions. The section and subsection headings of this Warrant are inserted for convenience only and shall not
constitute a part of this Warrant in construing or interpreting any provision hereof. 
 14. Governing Law. This Warrant shall be
governed by and construed under the laws of the State of Utah as applied to agreements among Utah residents entered into and to be performed entirely within Utah, without reference to principles of conflict of laws or choice of laws. 

15. Notices. Any notice or other communication required or permitted to be given under this Note shall be in writing, shall be
delivered by hand or overnight courier service, by certified mail, postage prepaid, or by facsimile or e-mail, and will be deemed given upon delivery, if delivered personally, one business day after deposit with a national courier service for
overnight delivery, or one business day after transmission by facsimile or e-mail with confirmation of receipt, and three days after deposit in the mails, if mailed, to the following addresses: 

If to the Company: 
 Great Basin
Scientific, Inc. 
 2441 South 3850 West 

Salt Lake City, UT 84120 

Attention: Ryan Ashton, President & CEO 

If to Holder: 

[                    ], at the address set
forth on the signature page hereto. 
 16. Representations of the Holder. The Holder hereby represents and warrants to the
Company as follows: 
 (a) Investment. The Holder understands that the investment in this Warrant (as well as the
securities issuable upon exercise of the Warrant) is a speculative investment and represents that the Holder is aware of the business affairs and financial condition of the Company and has acquired sufficient information about the Company to reach
an informed and knowledgeable decision to acquire such securities. Moreover the Holder acknowledges that the Warrant is being acquired for investment for the Holder’s own account, not as a nominee or agent, and not with a view to the resale or
distribution of 

  
 4 

 
any part thereof, and that the Holder has no present intention of selling, granting any participation in, or otherwise distributing the same. The Holder further understands that neither the
Warrant nor underlying securities have been registered under the Securities Act of 1933, as amended (the “Securities Act”), or applicable state securities laws by reason of specific exemptions therefrom, which exemptions
depend on, among other things, the bona fide nature of the Holder’s investment intent as expressed herein. 
 (b)
Disclosure of Information. The Holder acknowledges that the Holder has received and reviewed this Warrant and all the information the Holder considers necessary or appropriate for deciding whether to make this investment and accept this
Warrant. The Holder further represents that the Holder has had an opportunity to ask questions and receive answers from the Company regarding the business, properties, prospects and financial condition of the Company and to consult with counsel of
the Holder’s choosing regarding the terms and conditions of this investment. 
 (c) Investment Experience. The
Holder is an investor in securities of companies in the development stage and acknowledges that it is able to fend for itself, can bear the economic risk of its investment, and has such knowledge and experience in financial or business matters that
it is capable of evaluating the merits and risks of this investment. If other than an individual, the Holder also represents that it has not been organized for the purpose of acquiring this Warrant and is duly authorized to make this investment.

 (d) Accredited Investor. The Holder is an “accredited investor” within the meaning of U.S. Securities and
Exchange Commission (“SEC”) Rule 501 of Regulation D, as presently in effect, promulgated under the Securities Act. 

(e) Restricted Securities. The Holder understands that the securities issuable upon exercise of the Warrant will be
characterized as “restricted securities” under the United States federal securities laws inasmuch as they would be acquired from the Company in a transaction not involving a public offering and that under such laws and applicable
regulations such securities may be resold without registration under the Securities Act only in certain limited circumstances. In this connection, the Holder represents that the Holder is familiar with SEC Rule 144, as presently in effect, and
understands the resale limitations imposed thereby and by the Securities Act. 
 (f) Legends. It is understood that
the certificates evidencing the Securities issuable upon exercise of the Warrant may bear the following legend: 
 THE SHARES REPRESENTED
BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”) OR ANY STATE SECURITIES LAWS. THE SHARES MAY NOT BE SOLD OR OTHERWISE TRANSFERRED UNLESS THE SHARES ARE REGISTERED
UNDER THE ACT AND UNDER APPLICABLE STATE SECURITIES LAWS OR UNLESS THE COMPANY RECEIVES AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT AN EXEMPTION FROM REGISTRATION IS AVAILABLE. 

  
 5 

 17. Market Stand-Off. In connection with any underwritten public offering by the Company
of its equity securities pursuant to an effective registration statement filed under the Securities Act, including the Company’s initial public offering, the Holder shall not directly or indirectly sell, make any short sale of, loan,
hypothecate, pledge, offer, grant or sell any option or other contract for the purchase of, purchase any option or other contract for the sale of, or otherwise dispose of or transfer, or agree to engage in any of the foregoing transactions with
respect to, any shares acquired under this Warrant without the prior written consent of the Company or its underwriters. Such restriction (the “Market Stand-Off”) shall be in effect for such period of time following the date
of the final prospectus for the offering as may be requested by the Company or such underwriters. In no event, however, shall such period exceed 180 days. The Market Stand-Off shall in any event terminate two years after the date of the
Company’s initial public offering. In the event of the declaration of a stock dividend, a spin-off, a stock split, an adjustment in conversion ratio, a recapitalization or a similar transaction affecting the Company’s outstanding
securities without receipt of consideration, any new, substituted or additional securities which are by reason of such transaction distributed with respect to any shares subject to the Market Stand-Off, or into which such shares thereby become
convertible, shall immediately be subject to the Market Stand-Off. In order to enforce the Market Stand-Off, the Company may impose stop-transfer instructions with respect to the shares acquired under this Warrant until the end of the applicable
stand-off period. The Company’s underwriters shall be beneficiaries of the agreement set forth in this Section 17. This Section 17 shall not apply to shares registered in the public offering under the Securities Act, and the Holder
shall be subject to this Section 17 only if the directors and officers of the Company are subject to similar arrangements. 

[Signature page follows] 

  
 6 

 IN WITNESS WHEREOF, the Company caused this Warrant to be executed by an officer thereunto
duly authorized. 
  

			
	GREAT BASIN SCIENTIFIC, INC.
		
	By:	 	  

	Name:	 	  

	Its:	 	  

 ACCEPTED AND AGREED: 

[                         
                               ] 

 

			
	Address:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00235-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00235-of-00352.parquet"}]]